ABOUT LETROKEY™-2.5 TABLETS
LETROKEY™-2.5 contains Letrozole USP 2.5 mg, an aromatase inhibitor that works by reducing oestrogen production. In reproductive medicine, letrozole is used in selected fertility treatment protocols, including ovulation induction in certain women. The 2.5 mg tablet provides a measured oral dose for treatment schedules where letrozole therapy has been prescribed.
What's Inside?
| Ingredient | Packing |
|---|---|
| Letrozole USP 2.5mg | 10 × 5 Blister |
Why Curo360 Lifesciences?
As a focused gynae pharma company, Curo360 brings together a carefully developed portfolio covering key areas of gynaecological care.
Gynaecology
at the Core
A clear focus across
women’s health segments.
Purposeful Product
Portfolio
Formulations around specific healthcare needs.
Coverage That
Goes Deeper
Key therapeutic areas
under one portfolio.
Evolving with
Healthcare Needs
A range that grows with changing requirements.










